Dhurandhar To KGF 2: Sanjay Dutt's 8 Highest-Grossing Bollywood Hits
After a series of flops, Sanjay Dutt struck gold with Dhurandhar, marking a turning point in his career. Here's a look at his highest net-collecting films at the Indian box office.
KGF 2 stands as the highest-grossing film of Sanjay Dutt's career. Released in 2022, it earned an impressive ₹435.33 crore net at the Indian box office, cementing its place as a major commercial success.
Sanjay Dutt's recent release Dhurandhar has emerged as the second highest-grossing film of his career, earning a net of ₹152.75 crore at the Indian box office and marking a significant commercial success.
Sanjay Dutt's 2012 film Agneepath ranks as the third highest-grossing film of his career, collecting a net of ₹118.2 crore at the Indian box office and earning acclaim for its intense performances.
Sanjay Dutt's 2019 film Kalank is the fourth highest-grossing film of his career, earning a net of ₹84.6 crore at the Indian box office and drawing attention for its star-studded cast and grand production.
Sanjay Dutt's 2006 film Lage Raho Munna Bhai earned a net of ₹76.65 crore at the Indian box office, making it one of the top-grossing films of his career and a beloved hit among audiences.
Sanjay Dutt's 2022 film Samrat Prithviraj earned a net of ₹68.14 crore at the Indian box office, adding to his list of commercially successful films and showcasing his enduring appeal among audiences.
Sanjay Dutt's 2025 release Baaghi 4 earned a net of ₹53.38 crore at the Indian box office, continuing his streak of successful films and drawing audiences with its high-octane action and star power.
Sanjay Dutt's 2011 film Double Dhamaal earned a net of ₹44.1 crore in India, making it the eighth highest-grossing film of his career and a notable success in his comedy repertoire.
It's worth noting that Sanjay Dutt has faced a series of box office flops in recent years. Most of his films after KGF 2, including Samrat Prithviraj, Shamshera, and Baaghi 4, failed to make a significant impact commercially.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment